The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia

  • STATUS
    Recruiting
  • End date
    Mar 28, 2025
  • participants needed
    90
  • sponsor
    University of Illinois at Chicago
Updated on 19 February 2024
strength training
hypertension
resistance training
sarcopenia

Summary

Current prevention and treatment of high blood pressure (BP) in sarcopenia, by non-pharmacological approaches remain limited and are far from optimal. This randomized control intervention pilot study will provide new evidence of the unexplored relationship between muscle strength and high BP in sarcopenia, and experimentally test the effects of an evidence-based progressive resistance training intervention on BP, while also examining reversibility to identify muscle strength as a non-pharmacological target for BP control in older sarcopenic adults.

Description

This premise of this K01 proposal is to address current gaps in the literature regarding the understanding of high blood pressure due to sarcopenia, and provide new evidence for the discernible relationship between low muscle strength and blood pressure in sarcopenia, and effective non-pharmaceutical treatment approaches. This study will evaluate the feasibility of recruitment, retention, implementation and adherence to an empirically-based progressive resistance training (PRT) intervention to test its effect on blood pressure in a targeted population of older adults with sarcopenia who are randomized (via block permuted scheme) to the PRT intervention. Built within this randomized control intervention design, the investigators will further explore reversibility to examine whether muscle strength serves as an intervention target for blood pressure control in sarcopenic adults, which will be more appropriately tested in subsequently well-powered R-level intervention studies. Physiologically plausible microvascular mechanisms by which the PRT impacts changes in blood pressure will also be explored.

Details
Condition Vascular Diseases, Vascular Diseases, Hypertension, Sarcopenia
Age 65years - 100years
Treatment Progressive Resistance Training
Clinical Study IdentifierNCT04255745
SponsorUniversity of Illinois at Chicago
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Adults (men and women) aged 65 years and older (any racial/ethnic background)
Sedentary or low active adults (not active in strength training)

Exclusion Criteria

Subjects with self-report of inability to walk at least mile or walk 400 meters in <15 minutes without sitting
Subjects who self-reported having a history of a cardiovascular disease (CVD) event or physician diagnosed CVD (heart attack, heart failure, peripheral vascular disease, coronary revascularization, or angina that required overnight hospitalization)
Subjects history of mental illness (bipolar, multiple personality disorder), or cognitive impairment (e.g., dementia, Alzheimer's)
Subjects with orthopedic pathology or deformity that prevents exercising safely
Subjects with active cancer (i.e., recent physician diagnosis, currently receiving treatment, or in remission)
Subjects with lupus, multiple sclerosis
Lidocaine allergy
Participants from the same household as those already enrolled in the study
Baseline Montreal Cognitive Assessment score of <22 (adjusted by adding 2 points for education 4-9, 1 point for education 10-12 years)
Current participation in another exercise study
Currently is- or has a history of abusing alcohol or illicit drugs
Subjects who plan to move in the next 6 months or take an extended vacation
Non-english speakers
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study AnnotationsStudy Notes

Notes added here are public and can be viewed by anyone. Notes added here are only available to you and those who you share with.

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.